Home › Bronchiolitis Obliterans Syndrome › Oregon
Bronchiolitis Obliterans Syndrome clinical trials in Oregon
6 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Oregon.
Cities in Oregon
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Oregon Health and Science University, Portland
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Oregon Health Sciences University, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511A Long-term Extension Study of PCI-32765 (Ibrutinib)
- Willamette Valley Cancer Center, Eugene
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT01804686A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Oregon Health & Science University, Portland
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Oregon Health & Science University, Portland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Oregon Health and Science University, Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.